Back

Great Debate: anticoagulation for stroke prevention in atrial fibrillation – the grey zone – discussion.

28 August 2021 (08:30 - 08:45)
Organised by:
Congress Presentation Part of: Great Debate: anticoagulation for stroke prevention in atrial fibrillation – the grey zone Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

2 More presentations in this session

Presentation thumbnail
Anticoagulation should be given to all patients with atrial fibrillation and CHA2DS2-VASc score of 1: pro.
Professor G. Lip (Liverpool, GB)
Slides
Presentation thumbnail
Anticoagulation should be given to all patients with atrial fibrillation and CHA2DS2-VASc score of 1: con.
Professor A. Niessner (Vienna, AT)
Slides

Access the full session

Session thumbnail
Great Debate: anticoagulation for stroke prevention in atrial fibrillation – the grey zone
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources